Lipum Past Earnings Performance
Past criteria checks 0/6
Lipum's earnings have been declining at an average annual rate of -23.3%, while the Biotechs industry saw earnings growing at 17.7% annually. Revenues have been declining at an average rate of 79.8% per year.
Key information
-23.3%
Earnings growth rate
-7.1%
EPS growth rate
| Biotechs Industry Growth | 0.7% |
| Revenue growth rate | -79.8% |
| Return on equity | -813.2% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Lipum makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -37 | 37 | 0 |
| 30 Sep 23 | 0 | -41 | 40 | 0 |
| 30 Jun 23 | 0 | -44 | 44 | 0 |
| 31 Mar 23 | 0 | -39 | 39 | 0 |
| 31 Dec 22 | 0 | -38 | 38 | 0 |
| 30 Sep 22 | 0 | -54 | 55 | 0 |
| 30 Jun 22 | 0 | -50 | 51 | 0 |
| 31 Mar 22 | 0 | -52 | 53 | 0 |
| 31 Dec 21 | 0 | -52 | 53 | 0 |
| 30 Sep 21 | 5 | -33 | 25 | 0 |
| 31 Dec 20 | 11 | -21 | 4 | 0 |
| 31 Dec 19 | 10 | -9 | 3 | 0 |
| 31 Dec 18 | 3 | -2 | 1 | 0 |
| 31 Dec 17 | 0 | -2 | 0 | 0 |
Quality Earnings: LIPUM is currently unprofitable.
Growing Profit Margin: LIPUM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LIPUM is unprofitable, and losses have increased over the past 5 years at a rate of 23.3% per year.
Accelerating Growth: Unable to compare LIPUM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LIPUM is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-11.5%).
Return on Equity
High ROE: LIPUM has a negative Return on Equity (-813.17%), as it is currently unprofitable.